Although there was no statistically significant difference in hs-CRP reduction between the groups at 30 days after the completion of treatment, we nevertheless observed a clear trend toward lower hs-CRP levels in the statin-STS group as compared to the control group.
← all excerpts
Sodium tanshinone IIA sulfate adjunct therapy reduces high-sensitivity C-reactive protein level in coronary artery disease patients: a randomized controlled trial.
1
—
—